Are Your Artificial Intelligence Vendors Training Models on Your Patient Data?

Every week, healthcare organizations are pitched new tools promising to automate clinical documentation, speed up revenue cycle work, or optimize scheduling. The pitch deck displays a compliance badge prominently. Look past the marketing and into the fine print of the master services agreement, and a critical legal gap frequently emerges.

Many commercial providers include broad data usage rights in their standard terms. Unless procurement and legal know exactly where to look, an organization can inadvertently grant a vendor permission to use patient-derived data to train its commercial models.

The product improvement trap

Vendor contracts routinely contain clauses allowing the vendor to retain, analyze, and process customer content for system optimization, algorithm tuning, or product improvement.

That sounds unremarkable for traditional software. In the context of a generative model, it creates severe exposure. If the terms permit the model to learn from your clinical notes or patient interactions, protected health information or derivative signals may be absorbed into model weights, a process that is effectively impossible to reverse.

What happens to the derivatives

When patient data is processed by a model, the system generates intermediate products: vector embeddings, summary tokens, and inferences. Does your agreement explicitly define who owns them? If the contract is silent, the vendor may claim ownership of those mathematical representations of your patient data, and use them to refine products sold to your competitors.

Three steps before signature